Coeptis Pharmaceuticals, Inc. entered into a binding agreement to acquire Elto Pharma, Inc. from PsychoGenics Inc. and Amarantus BioScience Holdings, Inc. (OTCPK:AMBS) on November 28, 2018. Coeptis will issue 7.5 million shares as part of consideration and an additional 7.5 million shares being delivered to Elto Pharma shareholders upon the completion of certain milestones.
Coeptis Therapeutics, Inc. OTC Markets
Equities
COEP
US19207C1045
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |